Description
GRAIL is a healthcare company dedicated to the early detection of cancer, aiming to lower the global cancer burden by developing innovative technology for identifying multiple deadly cancer types at an early stage when treatment is most effective. Utilizing next-generation sequencing, large-scale clinical studies, and advanced computer and data science, GRAIL enhances the understanding of cancer biology to create a multi-cancer early detection blood test. Headquartered in Menlo Park, CA, with additional locations in Washington, D.C., North Carolina, and the United Kingdom, GRAIL, LLC operates as a subsidiary of Illumina, Inc., which is currently kept separate under the European Commission's Interim Measures Order.
Additional Details
Contact Details
Gallery
No images found!
Video
No url found!
There are no reviews yet.